Evaluating the impact of Advice and Guidance on diagnostic pathways and healthcare use in England: retrospective cohort study, 2015-2022
This retrospective cohort study of over 71,000 patients in England found that while the use of Advice and Guidance (A&G) referrals was associated with longer diagnostic intervals for inflammatory bowel disease, Parkinson's disease, and systemic lupus erythematosus compared to elective referrals, it did not delay time to treatment or outpatient appointments, suggesting A&G may be utilized earlier in more complex diagnostic pathways rather than causing diagnostic delays.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the United Kingdom's National Health Service, a patient's journey from a general practitioner's office to a specialist's clinic is a central function of modern healthcare. When a family doctor suspects a complex condition, they traditionally send a formal referral, placing the patient on a waiting list for an outpatient appointment. In recent years, a different route has gained prominence: a process called "Advice and Guidance." This allows a primary care clinician to send a specific query to a specialist, asking for input on how to manage a patient's symptoms without necessarily sending the patient to the hospital immediately. The goal is to support the family doctor, manage care closer to home, and reduce the pressure on busy hospital waiting lists. However, a critical question remains for patients and health systems alike: does this shortcut actually speed up the path to a diagnosis and treatment, or does it inadvertently add an extra step that delays care for those who ultimately need a specialist's full assessment?
To answer this, researchers conducted a large-scale investigation using electronic health records from over 71,000 patients in England who were eventually diagnosed with one of three distinct conditions: inflammatory bowel disease, Parkinson's disease, or systemic lupus erythematosus. These conditions were chosen because they represent different ages and medical specialties, yet all require specialist input for a definitive diagnosis and treatment. The team compared two groups of patients: those who had a formal referral to a specialist and those who had an "Advice and Guidance" request recorded in their file before their diagnosis. By looking at the time elapsed between the first recorded contact with a specialist (either a referral or an advice request) and the final diagnosis, the researchers could see which path led to a quicker answer.
The study found that for patients who were eventually diagnosed, the path involving "Advice and Guidance" took longer to reach a diagnosis than the path involving a direct referral. Specifically, patients with inflammatory bowel disease waited an additional 15.9 weeks, those with Parkinson's disease waited an additional 11.4 weeks, and those with systemic lupus erythematosus waited an additional 6.3 weeks longer than their counterparts who were referred directly. This suggests that for these specific groups, the advice route did not shorten the diagnostic journey. However, the researchers were careful to note that this does not prove the advice process caused the delay. Instead, the data suggests that family doctors may be using "Advice and Guidance" earlier in the process for patients with more complex or confusing symptoms, meaning the clock starts ticking sooner for these patients even if the final diagnosis arrives later.
Despite the longer time to diagnosis, the study revealed that the "Advice and Guidance" route did not delay the start of treatment or the first hospital visit once the patient was ready. Patients in both groups received their first definitive medication and attended their first outpatient appointments at roughly the same time relative to when they began their specialist journey. This indicates that while the diagnostic interval was longer for the advice group, the actual treatment was not held up. Furthermore, the study found that patients who used the "Advice and Guidance" route tended to have more follow-up referrals to secondary care and more visits to their family doctor afterward, particularly for inflammatory bowel disease and lupus. This pattern suggests that the advice request might be part of a more complex diagnostic pathway where multiple steps are taken to clarify the condition, rather than a single shortcut.
The researchers also looked at whether this approach affected patient safety or the risk of emergency hospital admissions. They found no clear difference in the rates of unplanned hospital stays or mortality between the two groups. This is a reassuring finding, as it suggests that using "Advice and Guidance" did not lead to worse health outcomes in terms of immediate safety, even if the time to a formal diagnosis was extended. The study concludes that while "Advice and Guidance" is a valuable tool for supporting family doctors and managing care, it should not be viewed as a mechanism that automatically speeds up diagnosis for every patient. For those who ultimately require specialist care, the process may involve additional steps that extend the timeline, likely because these patients present with more complicated symptoms that require careful navigation. The findings highlight the need to monitor these pathways carefully to ensure that the system supports patients without creating unnecessary administrative hurdles or delays in their care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.